General Information |
| Summary |
This is a single centre, single arm, open-label study, to investigate the safety and efficacy of induction of neural stem cells transplantation in the brain. |
| Clinical trials phase |
Other |
| Start date (estimated) |
2019-03-01 |
| End date (estimated) |
2019-03-31 |
| Clinical feature |
| Label |
Ischemic Stroke |
| Link |
http://purl.obolibrary.org/obo/NCIT_C95802 |
| Description |
An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue. |
|
Administrative Information |
| NCT number |
NCT03725865 |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=NCT03725865 |
| Other study identifiers |
|
| Source weblink |
https://clinicaltrials.gov/ct2/show/NCT03725865 |
| Public contact |
| Email |
alife |
| Public email |
allife@allifetech.com |
| First name |
allife@allifetech.com |
| City |
Beijing |
| Country |
|
|
| Sponsors |
Allife Medical Science and Technology Co., Ltd.
|
Cells |
| Which differentiated cell type is used |
| Label |
neural stem cell |
| Link |
http://purl.obolibrary.org/obo/CL_0000047 |
| Description |
An undifferentiated neural cell that originates from the neuroectoderm and has the capacity both to perpetually self-renew without differentiating and to generate multiple central nervous system neuronal and glial cell types. |
|
Recruitment |
| Recruitment Status |
Unknown Status |
| Estimated number of participants |
12 |
